Company News
August 2009
Promius Pharma, LLC has announced the launch of Promiseb™ Topical Cream, a non-steroidal, prescription only, cream for the treatment of seborrheic dermatitis, that has demonstrated both anti-inflammatory and antifungal properties.
January 2009
Promius Pharma, LLC, has launched Scytera™(coal tar) Foam 2% for the treatment of chronic psoriasis, a skin disease that affects approximately 7.5 million Americans according to The National Psoriasis Foundation.
October 2008
Promius Pharma, LLC, a wholly owned subsidiary of Dr. Reddy's Laboratories (NYSE: RDY), announced the launch of its first product, EpiCeram® Skin Barrier Emulsion.
September 18, 2008
Dr. Reddy's formally announces its US Specialty Business, Promius Pharma, LLC
September 03, 2008
Antares Pharma enters into a feasibility development agreement with Dr. Reddy's Laboratories for an enhanced dermatology product utilizing the ATD gel platform.
September 27, 2007
Sinclair Pharma plc announces Dr Reddy's Laboratories as Sebclair marketing partner in US.
November 14, 2007
Ceragenix and Dr. Reddy's enter into distribution and supply agreement for EpiCeram®.
January 24, 2007
Foamix signs R&D collaboration and license agreement with Dr. Reddy's for the development and commercialization of psoriasis foam.
